Details for New Drug Application (NDA): 205576
✉ Email this page to a colleague
The generic ingredient in PROPOFOL is propofol. There are twelve drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the propofol profile page.
Summary for 205576
| Tradename: | PROPOFOL |
| Applicant: | Innopharma |
| Ingredient: | propofol |
| Patents: | 0 |
Pharmacology for NDA: 205576
| Physiological Effect | General Anesthesia |
Medical Subject Heading (MeSH) Categories for 205576
Suppliers and Packaging for NDA: 205576
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| PROPOFOL | propofol | INJECTABLE;INJECTION | 205576 | ANDA | Pfizer Laboratories Div Pfizer Inc | 0069-0209 | 0069-0209-10 | 10 VIAL in 1 CARTON (0069-0209-10) / 20 mL in 1 VIAL (0069-0209-01) |
| PROPOFOL | propofol | INJECTABLE;INJECTION | 205576 | ANDA | Pfizer Laboratories Div Pfizer Inc | 0069-0234 | 0069-0234-20 | 20 VIAL in 1 CARTON (0069-0234-20) / 50 mL in 1 VIAL |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 10MG/ML | ||||
| Approval Date: | Sep 16, 2020 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
